MARKET

TCRT

TCRT

Alaunos Therapeutics, Inc
NASDAQ
0.1292
-0.0026
-1.97%
Closed 18:39 10/02 EDT
OPEN
0.1294
PREV CLOSE
0.1318
HIGH
0.1347
LOW
0.1263
VOLUME
547.52K
TURNOVER
--
52 WEEK HIGH
1.850
52 WEEK LOW
0.1111
MARKET CAP
31.09M
P/E (TTM)
-0.8045
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TCRT last week (0925-0929)?
Weekly Report · 22h ago
Alaunos Therapeutics, Inc: Current report
Press release · 4d ago
Weekly Report: what happened at TCRT last week (0918-0922)?
Weekly Report · 09/25 12:14
Weekly Report: what happened at TCRT last week (0911-0915)?
Weekly Report · 09/18 12:05
Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 09/14 16:58
Weekly Report: what happened at TCRT last week (0904-0908)?
Weekly Report · 09/11 12:03
Alaunos Therapeutics, Inc: Statement of changes in beneficial ownership of securities
Press release · 09/05 22:11
Weekly Report: what happened at TCRT last week (0828-0901)?
Weekly Report · 09/05 08:48
More
About TCRT
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. It is engaged in developing adoptive TCR engineered T-cell therapies (TCR-T), designed to treat multiple solid tumor types in large cancer patient populations. It is leveraging its cancer mutation hotspot TCR library and its non-viral Sleeping Beauty genetic engineering technology to design and manufacture patient-specific cell therapies that target neoantigens arising from common tumor-related mutations in oncogenic genes, including KRAS, TP53 and EGFR. Its TCR library consists of ten TCRs targeting six solid tumor indications, such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian and bile duct cancers. Using its human neoantigen T cell Receptor discovery engine, it analyzes thousands of single T cells simultaneously using bioinformatics and next generation sequencing. Its pipeline in cell therapy for oncology consists of Library TCR-T cell therapy and mbIL-15 TCR-T cell therapy.

Webull offers kinds of Alaunos Therapeutics Inc stock information, including NASDAQ:TCRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCRT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCRT stock methods without spending real money on the virtual paper trading platform.